DMI Life Sciences

DMI Life Sciences, Inc. is a biotechnology company. It discovers and develops small molecule and peptide-based drugs and biomarkers for acute and chronic inflammation. The company focuses on immune, vascular, and central nervous system diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer's disease, asthma, and cancer.